We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GENERIC-BRAND DEALS MUST BE REPORTED BEFORE MARKETING
GENERIC-BRAND DEALS MUST BE REPORTED BEFORE MARKETING
January 13, 2004
Generic and brand drugmakers must inform federal antitrust regulators when they settle disputes over the launch of generic versions of brand drugs.